Acticor Biotech

📍 Paris, France🗓 Founded 2013👥 25 employees💰 Last funded Oct 2019
Biotechnology🌐 acticor-biotech.com
Website LinkedIn
Acticor Biotech is a spin-off from Inserm (French National Institute of Health and Medical Research) dedicated to the development of an innovative therapeutic strategy for a safe and effective emergency treatment of ischemic strokes which account for 80% of all strokes. Acticor Biotech’s project stems from the sheer need for new therapeutic options to manage stroke. According to the World Health Organization, 15 million people suffer stroke worldwide each year. Of these, 5 million die and another 5 million are permanently disabled. Stroke is the third cause of death in the world and the leading cause of death among women. It is also the first cause of adult acquired disabilities resulting from the neurological damages sustained by 75% of the survivors. However only one treatment is presently recommended by health authorities and is it estimated that only 15% of ischemic stroke patients are treated with it, with less that 40% efficacy. So while this treatment is very useful for ischemic stroke, a major need for a new treatment capable of effectively treating a majority of ischemic stroke patients remains. This project is based on the academic research from Acticor Biotech founders Dr. M. Jandrot-Perrus and Prof. P. Billiald. It was supported by top institutions including the ANR (The French National Research Agency), the Fondation de France. The project also won the 2012 national prize for innovation in creation & development category from the BPI (French Public Investment Bank, formerly Oseo).
5
Total investors
0
Early stage
3
Mid stage
2
Late stage
2013
Founded

Investors

5 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
France
4
United States
1
Investor activity2018–2019 · investors recorded per year
2018320192
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Acticor Biotech?
Acticor Biotech has 5 investors on record on gritt.io, 3 mid-stage and 2 late-stage investors.
When did Acticor Biotech last raise funding?
The most recent investment in Acticor Biotech recorded on gritt.io was in October 2019.
When was Acticor Biotech founded?
Acticor Biotech was founded in 2013.
What industry is Acticor Biotech in?
Acticor Biotech operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is Acticor Biotech based?
Acticor Biotech is headquartered in Paris, France.